alexa Articles-on-novel-drug-designing|OMICS International|Drug Designing: Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Articles On Novel Drug Designing

Cholera is a serve diarrheal disease that remains a major health risk in developing countries. As a causative agent of Cholera, the bacterium Vibrio cholerae remains responsible for significant morbidity and mortality worldwide. The emergence and spread of multi-drug resistance Vibrio cholerae strains during past two decades is now a major problem in the treatment of cholera and have created the urgent need for the development of novel therapeutic agents. Targeting transcriptional factor is now a novel approach to tackle the development of multi-drug resistance strain. Vs Bijendra Khadka , Computer based screening for novel inhibitors against V. cholerae using NCI diversity set-II and ZINC natural products database.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on July, 2014